sponsored
PatientsVille.com Logo

PatientsVille

Metronidazole and Cephalexin

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectMetronidazoleCephalexin
DIARRHOEA3.5% 2.4%
NAUSEA3.4% 2.8%
PAIN2.2% 3.3%
DRUG INEFFECTIVE2.7% 1.4%
FATIGUE1.9% 2.5%
VOMITING2.5% 1.8%
PYREXIA2.5% 1.4%
DYSPNOEA1.9% 2.3%
ANXIETY1.4% 2.3%
HEADACHE2.2% 1.8%
DIZZINESS2.1% 1.9%
CHRONIC KIDNEY DISEASE0.7% 1.9%
ABDOMINAL PAIN1.8% 1.2%
RENAL FAILURE1.1% 1.8%
RASH1.6% 1.7%
DEPRESSION1% 1.7%
FALL0.8% 1.7%
INJURY0.8% 1.7%
ASTHENIA1.5% 1.6%
DRUG INTERACTION1.6% 0.5%
DRUG HYPERSENSITIVITY1.4% 1.5%
MALAISE1.5% 1.1%
ARTHRALGIA1.1% 1.5%
PAIN IN EXTREMITY1.1% 1.5%
URINARY TRACT INFECTION0.8% 1.5%
ACUTE KIDNEY INJURY1.1% 1.4%
HYPERTENSION0.8% 1.4%
PRURITUS1.3% 1.2%
ANAEMIA1.3% 1.1%
HYPOTENSION1.3% 0.9%
BACK PAIN0.8% 1.3%
CHEST PAIN0.8% 1.3%
CONFUSIONAL STATE1.3% 0.8%
DEEP VEIN THROMBOSIS0.7% 1.3%
PNEUMONIA1.2% 1.2%
SEPSIS1.2% 0.5%
WEIGHT DECREASED0.9% 1.1%
PARAESTHESIA1.1% 0.7%
OEDEMA PERIPHERAL0.6% 1.1%
CLOSTRIDIUM DIFFICILE INFECTION1.1% 0%
INSOMNIA0.9% 1%
ABDOMINAL PAIN UPPER1% 0.9%
PULMONARY EMBOLISM0.8% 1%
CONSTIPATION0.6% 1%
CONDITION AGGRAVATED1% 0.6%
COUGH0.6% 1%
EMOTIONAL DISTRESS0.5% 1%
MYOCARDIAL INFARCTION0% 1%
OFF LABEL USE1% 0%
PATHOGEN RESISTANCE1% 0%
DEATH0.9% 0.9%
DEHYDRATION0.8% 0.9%
DECREASED APPETITE0.9% 0.8%
HYPOAESTHESIA0.7% 0.9%
SEPTIC SHOCK0.9% 0%
CELLULITIS0% 0.9%
CEREBROVASCULAR ACCIDENT0% 0.9%
ERYTHEMA0.8% 0.7%
MUSCLE SPASMS0.7% 0.8%
GAIT DISTURBANCE0.8% 0.7%
NEUROPATHY PERIPHERAL0.8% 0.6%
HYPERSENSITIVITY0.8% 0.5%
DYSARTHRIA0.8% 0%
TOXICITY TO VARIOUS AGENTS0.8% 0%
THROMBOCYTOPENIA0.8% 0%
GASTROOESOPHAGEAL REFLUX DISEASE0% 0.8%
CARDIAC FAILURE CONGESTIVE0% 0.8%
CLOSTRIDIUM DIFFICILE COLITIS0.8% 0%
NEUTROPENIA0.8% 0%
TOXIC ENCEPHALOPATHY0.8% 0%
ECONOMIC PROBLEM0% 0.8%
URTICARIA0.7% 0.7%
DYSPHAGIA0.7% 0.6%
SOMNOLENCE0.7% 0.6%
TREMOR0.7% 0.6%
INFECTION0.7% 0.6%
GENERAL PHYSICAL HEALTH DETERIORATION0.7% 0.5%
BRONCHITIS0% 0.7%
SINUSITIS0% 0.7%
RESPIRATORY FAILURE0.7% 0%
ANAPHYLACTIC REACTION0.7% 0%
ALANINE AMINOTRANSFERASE INCREASED0.7% 0%
HAEMORRHAGE0.7% 0%
DYSGEUSIA0.7% 0%
TACHYCARDIA0.7% 0%
MYALGIA0.6% 0.6%
FEELING ABNORMAL0.6% 0.6%
ATRIAL FIBRILLATION0.6% 0.6%
PALPITATIONS0.5% 0.6%
RENAL FAILURE ACUTE0.6% 0.5%
MUSCULAR WEAKNESS0.6% 0.5%
HAEMOGLOBIN DECREASED0.6% 0.5%
WEIGHT INCREASED0% 0.6%
DIABETES MELLITUS0% 0.6%
CONTUSION0% 0.6%
CHOLELITHIASIS0% 0.6%
CORONARY ARTERY DISEASE0% 0.6%
ANHEDONIA0% 0.6%
OSTEOARTHRITIS0% 0.6%
ENCEPHALOPATHY0.6% 0%
EXPOSURE DURING PREGNANCY0.6% 0%
PANCYTOPENIA0.6% 0%
ABDOMINAL DISTENSION0.6% 0%
NEUROTOXICITY0.6% 0%
INTERNATIONAL NORMALISED RATIO INCREASED0.6% 0%
CHILLS0.5% 0.5%
ABDOMINAL DISCOMFORT0.5% 0.5%
ARTHRITIS0% 0.5%
SYNCOPE0% 0.5%
CHEST DISCOMFORT0% 0.5%
VISION BLURRED0% 0.5%
OSTEOPOROSIS0% 0.5%
CHRONIC OBSTRUCTIVE PULMONARY DISEASE0% 0.5%
HYPERHIDROSIS0% 0.5%
PERIPHERAL SWELLING0% 0.5%
CHOLECYSTITIS CHRONIC0% 0.5%
LOSS OF CONSCIOUSNESS0% 0.5%
DYSPEPSIA0% 0.5%
SWELLING0% 0.5%
END STAGE RENAL DISEASE0% 0.5%
DRUG DOSE OMISSION0% 0.5%
HEPATITIS0.5% 0%
CARDIAC ARREST0.5% 0%
ASPARTATE AMINOTRANSFERASE INCREASED0.5% 0%
SWELLING FACE0.5% 0%
COLITIS0.5% 0%
PLEURAL EFFUSION0.5% 0%
OEDEMA0.5% 0%
ATAXIA0.5% 0%
ALOPECIA0% 0.5%

New treatments are found every day. View current Metronidazole research studies and Cephalexin clinical trials

1